comparemela.com

Finally – after many false dawns – an effective new drug for Alzheimer’s is on the horizon. In early May, US scientists announced that the drug donanemab delays the worsening of symptoms by 35 per cent. Half the patients on the trial found their mental decline was halted for more than a year.

Related Keywords

Nuffield ,Oxfordshire ,United Kingdom ,Cornelia Cremens ,Thomas Littlejohns ,Hannah Churchill ,University Of Warwick ,Harvard Medical School ,Lancet Commission On Dementia ,University Of Oxford ,Nuffield Department Of Population Health At Oxford ,Alzheimer Research United Kingdom ,Alzheimer Society ,United Kingdom Biobank ,Nuffield Department ,Population Health ,Research United ,Lancet Commission ,General Psychiatry ,Harvard Medical ,Alzheimers Society ,Hearing Loss ,Dementia ,Katie Puckering ,Alzheimers Disease ,Risk ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.